about
Toxoplasma gondii soluble tachyzoite antigen triggers protective mechanisms against fatal intestinal pathology in oral infection of C57BL/6 miceAntibody and cytokine responses to house dust mite allergens and Toxoplasma gondii antigens in atopic and non-atopic Brazilian subjects.A4D12 monoclonal antibody recognizes a new linear epitope from SAG2A Toxoplasma gondii tachyzoites, identified by phage display bioselection.Effect of Toxoplasma gondii infection kinetics on trophoblast cell population in Calomys callosus, a model of congenital toxoplasmosisDetection of immunoglobulin G antibodies to Neospora caninum in humans: high seropositivity rates in patients who are infected by human immunodeficiency virus or have neurological disorders.Production, characterization and applications for Toxoplasma gondii-specific polyclonal chicken egg yolk immunoglobulins.Immunoglobulin M (IgM)-glycoinositolphospholipid enzyme-linked immunosorbent assay: an immunoenzymatic assay for discrimination between patients with acute toxoplasmosis and those with persistent parasite-specific IgM antibodies.Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in miceEffect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational ageToxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunityMacrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explantsAdjuvant and immunostimulatory effects of a D-galactose-binding lectin from Synadenium carinatum latex (ScLL) in the mouse model of vaccination against neosporosis.Reverse enzyme-linked immunosorbent assay using monoclonal antibodies against SAG1-related sequence, SAG2A, and p97 antigens from Toxoplasma gondii to detect specific immunoglobulin G (IgG), IgM, and IgA antibodies in human sera.SAG2A protein from Toxoplasma gondii interacts with both innate and adaptive immune compartments of infected hosts.Rottlerin-mediated inhibition of Toxoplasma gondii growth in BeWo trophoblast-like cellsThe involvement of heparin in retinal infection by Toxoplasma gondii in a chick model revealed an ontogenetic-dependent pattern.Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection.Taenia saginata metacestode antigenic fractions without affinity to concanavalin A are an important source of specific antigens for the diagnosis of human neurocysticercosis.Evaluation of indirect enzyme-linked immunosorbent assays and IgG avidity assays using a protein A-peroxidase conjugate for serological distinction between Brucella abortus S19-vaccinated and -infected cows.Down-modulation of nitric oxide production in murine macrophages treated with crude plant extracts from the Brazilian Cerrado.Differential susceptibility of human trophoblastic (BeWo) and uterine cervical (HeLa) cells to Neospora caninum infection.Hydrophobic fraction of Taenia saginata metacestodes, rather than hydrophilic fraction, contains immunodominant markers for diagnosing human neurocysticercosis.Galectin-3 plays a modulatory role in the life span and activation of murine neutrophils during early Toxoplasma gondii infection.Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).Neospora caninum excreted/secreted antigens trigger CC-chemokine receptor 5-dependent cell migration.BeWo trophoblasts are unable to control replication of Toxoplasma gondii, even in the presence of exogenous IFN-gamma.Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.Toxoplasma gondii: the severity of toxoplasmic encephalitis in C57BL/6 mice is associated with increased ALCAM and VCAM-1 expression in the central nervous system and higher blood-brain barrier permeability.Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice.Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii.Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.ArtinM, a D-mannose-binding lectin from Artocarpus integrifolia, plays a potent adjuvant and immunostimulatory role in immunization against Neospora caninum.Flow cytometry-based algorithm to analyze the anti-fixed Toxoplasma gondii tachyzoites IgM and IgG reactivity and diagnose human acute toxoplasmosis.Analysis of IgG subclasses (IgG1 and IgG3) to recombinant SAG2A protein from Toxoplasma gondii in sequential serum samples from patients with toxoplasmosisAnnexin A1 peptide is able to induce an anti-parasitic effect in human placental explants infected by Toxoplasma gondiiGalectin-3 is essential for reactive oxygen species production by peritoneal neutrophils from mice infected with a virulent strain of Toxoplasma gondiiCytokines and chemokines production by mononuclear cells from parturient women after stimulation with live Toxoplasma gondiiImmunoproteomics of Brucella abortus reveals differential antibody profiles between S19-vaccinated and naturally infected cattleBothrops pirajai snake venom L-amino acid oxidase: in vitro effects on infection of Toxoplasma gondii in human foreskin fibroblasts
P50
Q27305548-90054A4F-3E53-4C09-9FC0-7A2F5B140D01Q30433210-6581EB6C-3CE2-4288-8B27-D545239C433EQ33414917-EDAE1BDF-D95A-4E26-9919-983D26D07AE4Q34261636-C71C56E1-BB2C-4125-80F9-7BE26B00FD75Q34325873-90A8B8D8-102C-49FE-85B9-8FF42A034FCAQ34341987-1D256818-D90A-4EB6-A145-D3EFAE2D464AQ34455777-4AB7B585-90B4-4ADA-BFCA-D65BFFCCA1C7Q34665901-70E6ADE2-25D8-493A-8A77-63B0FBE7B7B3Q35071395-8DC57341-198F-42C6-B8E7-C15B39F4567AQ35088408-A22D0BBF-13BE-4FA8-A0D8-DFFE190F2496Q36357440-8EA1F93C-74F0-4295-992F-5603F6F502A3Q36640947-0EA4293E-80FD-4275-AA68-04604A588979Q36844910-931B5B17-8D9D-41BF-900B-3F4C5B90DEB1Q36996512-39DB685B-9DD1-4DB5-A72C-2FD2BC633408Q38705552-54CA6CDF-E20D-46FC-8DDA-AB6CDAC9C778Q39043955-0A652D11-A598-4978-88EE-ED9806489E10Q39476168-37462F65-5E54-427F-A486-51A4255C9E4FQ39894706-FBE468DD-4897-4809-8241-65F057652C48Q39894858-580A01B0-233A-42AC-856E-37F7B0380CA3Q40431529-2CB4A720-CB9F-4F58-AD09-D220EFB33799Q42937769-BDEC1E84-2210-4188-8B3B-315193B5B00FQ43012084-A523A427-8F5F-4FA1-B098-F87AD7E179BFQ43282966-B17B23C3-2E0A-4F5F-885B-7575C0182E12Q43286851-B6EB5934-EFF2-48A3-8B53-0DBA39A482AFQ44818984-35563CFF-9B36-4403-81C2-D99BB487BE71Q44950056-EEC27374-BE16-4EF8-8A99-9433C23553C8Q45364177-26042142-BF77-4C14-9E09-52250439F43CQ45776994-50BC1E71-A0B1-4B45-AD44-49CBCD17EF71Q46039029-9FB709C6-AFD0-450D-B1BE-35B62743DC5EQ47841101-B4F3DCF8-9862-4020-B9E0-D3FD9F1F151CQ48583196-B618C8B1-DD20-43E8-A6A1-4D752D993A94Q48690843-B019F254-B031-43C7-96F0-C5FE25C5D93FQ48836507-6445F65E-BD5A-44C6-ACA8-DC8EB7B456DBQ51421439-79C2FCF0-ADC1-40D2-8875-4A8F839A9DACQ56795220-A6C31EEB-4CDC-442D-A915-7E47DC826E2BQ58438857-4E20D3BF-D4CA-47C9-878B-09ECF2FE7D1DQ58438882-7B6D33DB-73F7-4C43-8A65-F27FE2E0EA0CQ58438904-2571640C-70B4-4662-984D-C1B9BBD55229Q58438919-7B5A7B84-8688-4E48-8B55-07BA9E5C302FQ58438941-06D8DEE0-8DED-430C-90E3-FCC67C624B97
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
José Roberto Mineo
@ast
José Roberto Mineo
@en
José Roberto Mineo
@es
José Roberto Mineo
@nl
José Roberto Mineo
@sl
type
label
José Roberto Mineo
@ast
José Roberto Mineo
@en
José Roberto Mineo
@es
José Roberto Mineo
@nl
José Roberto Mineo
@sl
altLabel
Mineo JR
@en
prefLabel
José Roberto Mineo
@ast
José Roberto Mineo
@en
José Roberto Mineo
@es
José Roberto Mineo
@nl
José Roberto Mineo
@sl
P106
P21
P31
P496
0000-0002-9010-7228